114 related articles for article (PubMed ID: 16298530)
1. Apoptosis-inducing effect of epolactaene derivatives on BALL-1 cells.
Kuramochi K; Matsui R; Matsubara Y; Nakai J; Sunoki T; Arai S; Nagata S; Nagahara Y; Mizushina Y; Ikekita M; Kobayashi S
Bioorg Med Chem; 2006 Apr; 14(7):2151-61. PubMed ID: 16298530
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and applications of fluorescent and biotinylated epolactaene derivatives: Epolactaene and its derivative induce disulfide formation.
Kuramochi K; Yukizawa S; Ikeda S; Sunoki T; Arai S; Matsui R; Morita A; Mizushina Y; Sakaguchi K; Sugawara F; Ikekita M; Kobayashi S
Bioorg Med Chem; 2008 May; 16(9):5039-49. PubMed ID: 18375133
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of epolactaene analogs as DNA polymerases inhibitors.
Kuramochi K; Mizushina Y; Nagata S; Sugawara F; Sakaguchi K; Kobayashi S
Bioorg Med Chem; 2004 May; 12(9):1983-9. PubMed ID: 15080901
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of epolactaene derivatives: structural requirements for inhibition of Hsp60 chaperone activity.
Nagumo Y; Kakeya H; Yamaguchi J; Uno T; Shoji M; Hayashi Y; Osada H
Bioorg Med Chem Lett; 2004 Sep; 14(17):4425-9. PubMed ID: 15357965
[TBL] [Abstract][Full Text] [Related]
5. A novel lipid compound, epolactaene, induces apoptosis: its action is modulated by its side chain structure.
Nakai J; Kawada K; Nagata S; Kuramochi K; Uchiro H; Kobayashi S; Ikekita M
Biochim Biophys Acta; 2002 Mar; 1581(1-2):1-10. PubMed ID: 11960746
[TBL] [Abstract][Full Text] [Related]
6. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, selectively inhibits the activities of mammalian DNA polymerases and human DNA topoisomerase II.
Mizushina Y; Kobayashi S; Kuramochi K; Nagata S; Sugawara F; Sakaguchi K
Biochem Biophys Res Commun; 2000 Jul; 273(2):784-8. PubMed ID: 10873681
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of epolactaene derivatives as DNA polymerase inhibitors and anti-inflammatory compounds.
Mizushina Y; Kuramochi K; Ikawa H; Kuriyama I; Shimazaki N; Takemura M; Oshige M; Yoshida H; Koiwai O; Sugawara F; Kobayashi S; Sakaguchi K
Int J Mol Med; 2005 May; 15(5):785-93. PubMed ID: 15806299
[TBL] [Abstract][Full Text] [Related]
8. Transformation of thiols to disulfides by epolactaene and its derivatives.
Kuramochi K; Sunoki T; Tsubaki K; Mizushina Y; Sakaguchi K; Sugawara F; Ikekita M; Kobayashi S
Bioorg Med Chem; 2011 Jul; 19(14):4162-72. PubMed ID: 21708466
[TBL] [Abstract][Full Text] [Related]
9. Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity.
Nagumo Y; Kakeya H; Shoji M; Hayashi Y; Dohmae N; Osada H
Biochem J; 2005 May; 387(Pt 3):835-40. PubMed ID: 15603555
[TBL] [Abstract][Full Text] [Related]
10. The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity.
Xu L; Tao S; Wang X; Yu Z; Wang M; Chen D; Jing Y; Dong J
Bioorg Med Chem; 2006 Aug; 14(15):5351-6. PubMed ID: 16617020
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate.
Dodo K; Minato T; Noguchi-Yachide T; Suganuma M; Hashimoto Y
Bioorg Med Chem; 2008 Sep; 16(17):7975-82. PubMed ID: 18693020
[TBL] [Abstract][Full Text] [Related]
12. Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors.
Kakeya H; Onozawa C; Sato M; Arai K; Osada H
J Med Chem; 1997 Feb; 40(4):391-4. PubMed ID: 9046328
[No Abstract] [Full Text] [Related]
13. New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities.
Keller L; Beaumont S; Liu JM; Thoret S; Bignon JS; Wdzieczak-Bakala J; Dauban P; Dodd RH
J Med Chem; 2008 Jun; 51(12):3414-21. PubMed ID: 18503262
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
15. Selective synthesis of epolactaene featuring efficient construction of methyl (Z)-2-iodo-2-butenoate and (2R,3S,4S)-2-trimethylsilyl-2,3-epoxy-4-methyl- gamma-butyrolactone.
Tan Z; Negishi E
Org Lett; 2006 Jun; 8(13):2783-5. PubMed ID: 16774256
[TBL] [Abstract][Full Text] [Related]
16. Chemical synthesis and biological evaluation of palmerolide A analogues.
Nicolaou KC; Leung GY; Dethe DH; Guduru R; Sun YP; Lim CS; Chen DY
J Am Chem Soc; 2008 Jul; 130(30):10019-23. PubMed ID: 18598030
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxicity of some new eriocalyxin B derivatives.
Zhao Y; Niu XM; Qian LP; Liu ZY; Zhao QS; Sun HD
Eur J Med Chem; 2007 Apr; 42(4):494-502. PubMed ID: 17189663
[TBL] [Abstract][Full Text] [Related]
18. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
[TBL] [Abstract][Full Text] [Related]
19. Epoxide-containing side chains enhance antiproliferative activity of paullones.
Xie X; Lemcke T; Gussio R; Zaharevitz DW; Leost M; Meijer L; Kunick C
Eur J Med Chem; 2005 Jul; 40(7):655-61. PubMed ID: 15935900
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of artificial macrosphelides in the search for new apoptosis-inducing agents.
Matsuya Y; Kobayashi Y; Kawaguchi T; Hori A; Watanabe Y; Ishihara K; Ahmed K; Wei ZL; Yu DY; Zhao QL; Kondo T; Nemoto H
Chemistry; 2009 Jun; 15(23):5799-813. PubMed ID: 19370747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
